Molecular Signaling Distinguishes Early ER Positive Breast Cancer Recurrences Despite Adjuvant Tamoxifen.

被引：2
|
作者：
Liu, M. C. [1 ]
Dixon, J. M. [1 ]
Xuan, J. J. [1 ]
Riggins, R. B. [1 ]
Chen, L. [1 ]
Wang, C. [1 ]
Cho, Y. [1 ]
Zhu, Y. [1 ]
Jin, L. [1 ]
Zwart, A. [1 ]
Wang, M. [1 ]
Klimach, U. M. [1 ]
Wang, Y. J. [1 ]
Renshaw, L. [1 ]
Larionov, A. [1 ]
Miller, W. R. [1 ]
Clarke, R. [1 ]
机构：
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-S1-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S1-8
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Extended adjuvant tamoxifen for early breast cancer: A meta-analysis
    Amir, Eitan
    Al-Mubarak, Mustafa
    Tibau, Ariadna
    Templeton, Arnoud J.
    Ocana, Alberto
    Seruga, Bostjan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Adjuvant tamoxifen adherence in men with early stage breast cancer.
    Oke, Oluchi
    Niu, Jiangong
    Chavez-MacGregor, Mariana
    Zhao, Hui
    Giordano, Sharon Hermes
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Adjuvant antiestrogen therapy with Tamoxifen (Nolvadex) in early breast cancer (EBC)
    Dermendjieva, L
    Antonov, R
    Golemanova, E
    Mihailova, J
    Nikolov, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S4 - S4
  • [24] Adjuvant tamoxifen adherence in men with early-stage breast cancer
    Oke, Oluchi
    Niu, Jiangong
    Chavez-MacGregor, Mariana
    Zhao, Hui
    Giordano, Sharon H.
    CANCER, 2022, 128 (01) : 59 - 64
  • [25] Excellent Outcomes With Adjuvant Toremifene or Tamoxifen in Early Stage Breast Cancer
    Lewis, Jaime D.
    Chagpar, Anees B.
    Shaughnessy, Elizabeth A.
    Nurko, Jacob
    McMasters, Kelly
    Edwards, Michael J.
    CANCER, 2010, 116 (10) : 2307 - 2315
  • [26] Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
    Lewis, J. D.
    Chagpar, A. B.
    Shaughnessy, E. A.
    Edwards, M. J.
    CANCER RESEARCH, 2009, 69 (02) : 145S - 145S
  • [27] PTEN Protein Expression in Postmenopausal Steroid Receptor Positive Early Breast Cancer Patients Treated with Adjuvant Tamoxifen
    Milovanovic, Z. M.
    Susnjar, S. V.
    Plesinac-Karapandzic, V. S.
    Juranic, Z. D.
    Tatic, S. B.
    Dzodic, R. R.
    CANCER RESEARCH, 2010, 70
  • [28] Prognostic and predictive value of TFF1 for adjuvant endocrine therapy in Chinese women with early ER positive breast cancer: Comparing aromatase inhibitors with tamoxifen
    Zhou, Liheng
    Yan, Tingting
    Jiang, Yiwei
    Di, Genhong
    Shen, Zhenzhou
    Shao, Zhimin
    Lu, Jinsong
    BREAST, 2011, 20 (01) : 15 - 20
  • [29] A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors or Tamoxifen.
    Lintermans, A.
    Dieudonne, A-S
    Vanderhaegen, J.
    Henry, N. L.
    Laenen, A.
    Wildiers, H.
    Paridaens, R.
    Christiaens, M-R
    Smeets, A.
    Leunen, K.
    Amant, F.
    Vergote, I.
    Neven, P.
    CANCER RESEARCH, 2011, 71
  • [30] Extended Adjuvant Tamoxifen for Early Breast Cancer: A Meta-Analysis
    Al-Mubarak, Mustafa
    Tibau, Ariadna
    Templeton, Arnoud J.
    Cescon, David W.
    Ocana, Alberto
    Seruga, Bostjan
    Amir, Eitan
    PLOS ONE, 2014, 9 (02):
12345